Authors: Chu, XY Sanchez-Castano, GP Higaki, K Oh, DM Hsu, CP Amidon, GL

Citation: Xy. Chu et al., Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter, J PHARM EXP, 299(2), 2001, pp. 575-582

Authors: Oh, KT Oh, DM Hayreh, SS

Citation: Kt. Oh et al., Optic disc vasculitis, GR ARCH CL, 238(8), 2000, pp. 647-658

Authors: Jinno, J Oh, DM Crison, JR Amidon, GL

Citation: J. Jinno et al., Dissolution of ionizable water-insoluble drugs: The combined effect of pH and surfactant, J PHARM SCI, 89(2), 2000, pp. 268-274

Authors: Oh, KT Weleber, RG Lotery, A Oh, DM Billingslea, AM Stone, EM

Citation: Kt. Oh et al., Description of a new mutation in rhodopsin, Pro23Ala, and comparison with electroretinographic and clinical characteristics of the Pro23His mutation, ARCH OPHTH, 118(9), 2000, pp. 1269-1276

Authors: Surendran, N Covitz, KMY Han, HK Sadee, W Oh, DM Amidon, GL Williamson, RM Bigge, CF Stewart, BH

Citation: N. Surendran et al., Evidence for overlapping substrate specificity between large neutral aminoacid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist, PHARM RES, 16(3), 1999, pp. 391-395

Authors: Han, HK Rhie, JK Oh, DM Saito, G Hsu, CP Stewart, BH Amidon, GL

Citation: Hk. Han et al., CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs, J PHARM SCI, 88(3), 1999, pp. 347-350